One of the hot new cancer immunotherapy drugs, Merck Co.’s Keytruda, strongly benefited patients with melanoma, lung cancer and mesothelioma, according to three studies presented Sunday at the American Association for Cancer Research conference in Philadelphia. One study, comparing Keytruda to …
Source:Studies: Merck drug Keytruda effective against 3 cancers
Monday, April 20, 2015
Studies: Merck drug Keytruda effective against 3 cancers
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment